InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: Ajax133 post# 19753

Wednesday, 10/30/2013 2:28:47 PM

Wednesday, October 30, 2013 2:28:47 PM

Post# of 426504
That would be great Ajax. And as goseek just pointed out, I completely agree that if the FDA took any approach that approves the Vascepa label for Trigs of 200-500, everybody could be satisfied.

But the FDA won't do it! That's the end of it....period. Why won't they do it? That question has kept me awake at night! Because the FDA can not tolerate a paradigm shift in the treatment of cardiovascular disease in the USA. That would be an existential threat. The FDA has long-standing relationships with all the members of the BP club. (In politics, it's called cronyism). The FDA consists of Bureaucrats and if there is one thing bureaucrats know....it's where their bread is buttered!

Amarin isn't a member of the BP club and so it has no allegiance. What it has is a drug that could have the same impact on the Pharma industry that a terrorist group with the "bomb" would have on the existing world order. Possession of that drug by Amarin, with all that benefit it may bring to healthcare in this country...and the rest of the world, is not an acceptable option to the FDA. If they gave Amarin free reign to market Vascepa, that would be the start of a massive power shift in the industry....perhaps away from cronyism! The FDA can't have that happen.

Please don't misunderstand this, the FDA absolutely wants Vascepa to be successful, but in the hands of one of its cronies.....not in Amarin's. The FDA has other plans for Amarin, they want Amarin.....Dead!

IMHO, I'm disgusted and I'm drained.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News